Clinical characteristics and patient-reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study

被引:3
作者
Ahmed, Zubair [1 ,7 ]
Honomichl, Ryan [2 ,3 ]
Thompson, Stephen F. [4 ]
Cohen, Joshua M. [5 ]
Schuster, Andrew [2 ]
Thompson, Nicolas R. [2 ,3 ]
Lapin, Brittany [2 ,3 ]
Udeh, Belinda L. [3 ,6 ]
Campos, Verena Ramirez [5 ]
Krasenbaum, Lynda J. [5 ]
Katzan, Irene L. [2 ]
机构
[1] Cleveland Clin, Neurol Inst, Ctr Neurol Restorat, Headache Sect, Cleveland, OH USA
[2] Cleveland Clin, Neurol Inst, Ctr Outcomes Res & Evaluat, Cleveland, OH USA
[3] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH USA
[4] Teva Pharmaceut, Parsippany, NJ USA
[5] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[6] Cleveland Clin, Ctr Populat Hlth Res, Cleveland, OH USA
[7] Cleveland Clin, Neurol Inst, Ctr Neurol Restorat, 9500 Euclid Ave, C21, Cleveland, OH 44195 USA
来源
HEADACHE | 2023年 / 63卷 / 07期
关键词
burden; health-care resource use; health-related quality of life; migraine; work impairment; UNITED-STATES; PREVALENCE; BURDEN; IMPACT; POPULATION; DISABILITY;
D O I
10.1111/head.14527
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To describe differences in clinical and demographic characteristics between patients with episodic migraine (EM) or chronic migraine (CM) and determine the effect of migraine subtype on patient-reported outcome measures (PROM). Background: Prior studies have characterized migraine in the general population. While this provides a basis for our understanding of migraine, we have less insight into the characteristics, comorbidities, and outcomes of migraine patients who present to subspecialty headache clinics. These patients represent a subset of the population that bears the greatest burden of migraine disability and are more representative of migraine patients who seek medical care. Valuable insights can be gained from a better understanding of CM and EM in this population. Methods: We conducted a retrospective observational cohort study of patients with CM or EM seen in the Cleveland Clinic Headache Center between January 2012 and June 2017. Demographics, clinical characteristics, and patient-reported outcome measures (3-Level European Quality of Life 5-Dimension [EQ-5D-3L], Headache Impact Test-6 [HIT-6], Patient Health Questionnaire-9 [PHQ-9]) were compared between groups. Results: Eleven thousand thirty-seven patients who had 29,032 visits were included. More CM patients reported being on disability 517/3652 (14.2%) than EM patients 249/4881 (5.1%) and had significantly worse mean HIT-6 (67.3 +/- 7.4 vs. 63.1 +/- 7.4, p < 0.001) and median [interquartile range] EQ-5D-3L (0.77 [0.44-0.82] vs. 0.83 [0.77-1.00], p < 0.001), and PHQ-9 (10 [6-16] vs. 5 [2-10], p < 0.001). Conclusions: There are multiple differences in demographic characteristics and comorbid conditions between patients with CM and EM. After adjustment for these factors, CM patients had higher PHQ-9 scores, lower quality of life scores, greater disability, and greater work restrictions/unemployment.
引用
收藏
页码:908 / 916
页数:9
相关论文
共 23 条
[1]   The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results [J].
Adams, Aubrey Manack ;
Serrano, Daniel ;
Buse, Dawn C. ;
Reed, Michael L. ;
Marske, Valerie ;
Fanning, Kristina M. ;
Lipton, Richard B. .
CEPHALALGIA, 2015, 35 (07) :563-578
[2]   Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS) [J].
Blumenfeld, A. M. ;
Varon, S. F. ;
Wilcox, T. K. ;
Buse, D. C. ;
Kawata, A. K. ;
Manack, A. ;
Goadsby, P. J. ;
Lipton, R. B. .
CEPHALALGIA, 2011, 31 (03) :301-315
[3]   Migraine Epidemiology, Burden, and Comorbidity [J].
Burch, Rebecca C. ;
Buse, Dawn C. ;
Lipton, Richard B. .
NEUROLOGIC CLINICS, 2019, 37 (04) :631-+
[4]   Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items [J].
Hays, Ron D. ;
Bjorner, Jakob B. ;
Revicki, Dennis A. ;
Spritzer, Karen L. ;
Cella, David .
QUALITY OF LIFE RESEARCH, 2009, 18 (07) :873-880
[5]  
Katzan Irene, 2011, AMIA Annu Symp Proc, V2011, P683
[6]   A six-item short-form survey for measuring headache impact:: The HIT-6™ [J].
Kosinski, M ;
Bayliss, MS ;
Bjorner, JB ;
Ware, JE ;
Garber, WH ;
Batenhorst, A ;
Cady, R ;
Dahlöf, CGH ;
Dowson, A ;
Tepper, S .
QUALITY OF LIFE RESEARCH, 2003, 12 (08) :963-974
[7]   The PHQ-9 - Validity of a brief depression severity measure [J].
Kroenke, K ;
Spitzer, RL ;
Williams, JBW .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (09) :606-613
[8]   Migraine prevalence, disease burden, and the need for preventive therapy [J].
Lipton, R. B. ;
Bigal, M. E. ;
Diamond, M. ;
Freitag, F. ;
Reed, M. L. ;
Stewart, W. F. .
NEUROLOGY, 2007, 68 (05) :343-349
[9]   Prevalence and burden of migraine in the United States: Data from the American Migraine Study II [J].
Lipton, RB ;
Stewart, WF ;
Diamond, S ;
Diamond, ML ;
Reed, M .
HEADACHE, 2001, 41 (07) :646-657
[10]   Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences [J].
Lipton, Richard B. ;
Munjal, Sagar ;
Alam, Aftab ;
Buse, Dawn C. ;
Fanning, Kristina M. ;
Reed, Michael L. ;
Schwedt, Todd J. ;
Dodick, David W. .
HEADACHE, 2018, 58 (09) :1408-1426